Extensions for Using Data Elements from FHIR R5 in FHIR R4 - Downloaded Version null See the Directory of published versions
| Official URL: http://hl7.org/fhir/uv/xver/ValueSet/R5-regulated-authorization-basis-for-R4 | Version: 0.1.0 | |||
| Standards status: Trial-use | Maturity Level: 1 | Responsible: Biomedical Research and Regulation | Computable Name: R5RegulatedAuthorizationBasisForR4 | |
This cross-version ValueSet represents content from http://hl7.org/fhir/ValueSet/regulated-authorization-basis|5.0.0 for use in FHIR R4.
This value set is part of the cross-version definitions generated to enable use of the
value set http://hl7.org/fhir/ValueSet/regulated-authorization-basis|5.0.0 as defined in FHIR R5
in FHIR R4.
The source value set is bound to the following FHIR R5 elements:
RegulatedAuthorization.basis as ExampleAcross FHIR versions, the value set has been mapped as:
http://hl7.org/fhir/ValueSet/regulated-authorization-basis|5.0.0http://hl7.org/fhir/ValueSet/regulated-authorization-basis|4.3.0Note that all concepts are included in this cross-version definition because no concepts have compatible representations
Following are the generation technical comments:
All concepts in the comparison are have code literals listed as identical.
The source and target value sets have the same number of active concepts (10).
FHIR ValueSet http://hl7.org/fhir/ValueSet/regulated-authorization-basis|5.0.0, defined in FHIR R5 does not have any mapping to FHIR R4
References
http://hl7.org/fhir/regulated-authorization-basis version 📍5.0.0| Code | Display |
| Bibliographical | Bibliographical application (stand-alone) |
| Full | Full application |
| KnownHumanBlood | Known human blood/plasma derived ancillary medicinal substance |
| KnownSubstance | Known active substance |
| NewSubstance | New active substance |
| ParallelTrade | Parallel traded products |
| SimilarBiological | Similar biological application |
| TemporaryUse | Authorizations for temporary use |
| TraditionalUse | Traditional use registration for herbal medicinal product application |
| Well-establishedUse | Well-established use application |
This value set expansion contains 10 concepts.
| System | Version | Code | Display | JSON | XML |
http://hl7.org/fhir/regulated-authorization-basis | 5.0.0 | Bibliographical | Bibliographical application (stand-alone) | ||
http://hl7.org/fhir/regulated-authorization-basis | 5.0.0 | Full | Full application | ||
http://hl7.org/fhir/regulated-authorization-basis | 5.0.0 | KnownHumanBlood | Known human blood/plasma derived ancillary medicinal substance | ||
http://hl7.org/fhir/regulated-authorization-basis | 5.0.0 | KnownSubstance | Known active substance | ||
http://hl7.org/fhir/regulated-authorization-basis | 5.0.0 | NewSubstance | New active substance | ||
http://hl7.org/fhir/regulated-authorization-basis | 5.0.0 | ParallelTrade | Parallel traded products | ||
http://hl7.org/fhir/regulated-authorization-basis | 5.0.0 | SimilarBiological | Similar biological application | ||
http://hl7.org/fhir/regulated-authorization-basis | 5.0.0 | TemporaryUse | Authorizations for temporary use | ||
http://hl7.org/fhir/regulated-authorization-basis | 5.0.0 | TraditionalUse | Traditional use registration for herbal medicinal product application | ||
http://hl7.org/fhir/regulated-authorization-basis | 5.0.0 | Well-establishedUse | Well-established use application |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |